rs753298014
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The ENST00000300527.9(COL6A2):āc.2008A>Gā(p.Thr670Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,612,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T670N) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000300527.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.2008A>G | p.Thr670Ala | missense_variant | 26/28 | ENST00000300527.9 | NP_001840.3 | |
COL6A2 | NM_058174.3 | c.2008A>G | p.Thr670Ala | missense_variant | 26/28 | ENST00000397763.6 | NP_478054.2 | |
COL6A2 | NM_058175.3 | c.2008A>G | p.Thr670Ala | missense_variant | 26/28 | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.2008A>G | p.Thr670Ala | missense_variant | 26/28 | 1 | NM_001849.4 | ENSP00000300527 | P1 | |
COL6A2 | ENST00000397763.6 | c.2008A>G | p.Thr670Ala | missense_variant | 26/28 | 5 | NM_058174.3 | ENSP00000380870 | ||
COL6A2 | ENST00000409416.6 | c.2008A>G | p.Thr670Ala | missense_variant | 25/27 | 5 | ENSP00000387115 | |||
COL6A2 | ENST00000413758.1 | c.679A>G | p.Thr227Ala | missense_variant | 11/11 | 3 | ENSP00000395751 |
Frequencies
GnomAD3 genomes AF: 0.0000725 AC: 11AN: 151746Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250310Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135728
GnomAD4 exome AF: 0.0000418 AC: 61AN: 1460634Hom.: 0 Cov.: 37 AF XY: 0.0000399 AC XY: 29AN XY: 726622
GnomAD4 genome AF: 0.0000725 AC: 11AN: 151746Hom.: 0 Cov.: 33 AF XY: 0.0000405 AC XY: 3AN XY: 74122
ClinVar
Submissions by phenotype
Neurogenic bladder;C0026826:Hypertonia;C0026838:Spasticity;C0026975:Myelitis;C0151786:Muscle weakness;C0151945:Cerebral venous thrombosis;C0231687:Spastic gait;C0948163:Abnormal cerebral white matter morphology;C1855710:Bone marrow hypocellularity;C2711630:Combined immunodeficiency;C4022749:Abnormal brainstem MRI signal intensity;C4022770:Abnormal thalamic MRI signal intensity Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Personalized Medicine, Children's Hospital Los Angeles | - | - - |
Bethlem myopathy 1A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This variant is present in population databases (rs753298014, gnomAD 0.003%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL6A2 protein function. ClinVar contains an entry for this variant (Variation ID: 598977). This missense change has been observed in individual(s) with clinical features of COL6A2-related conditions (PMID: 30755392). This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 670 of the COL6A2 protein (p.Thr670Ala). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 29, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at